{"id":2927,"date":"2016-11-08T19:15:58","date_gmt":"2016-11-08T19:15:58","guid":{"rendered":"http:\/\/www.medicalmarijuanainc.com\/?p=18192"},"modified":"2016-11-08T19:15:58","modified_gmt":"2016-11-08T19:15:58","slug":"medical-marijuana-inc-investment-company-axim-biotechnologies-secures-funding-clinical-trials","status":"publish","type":"post","link":"https:\/\/medicalmarijuanainc.com\/2016\/11\/08\/medical-marijuana-inc-investment-company-axim-biotechnologies-secures-funding-clinical-trials\/","title":{"rendered":"Medical Marijuana, Inc. Investment Company AXIM\u00ae Biotechnologies Secures Funding for Clinical Trials"},"content":{"rendered":"<p><span style=\"font-weight: 400\">Medical Marijuana, Inc. announced this week that AXIM\u00ae Biotechnologies secured the necessary private funding needed to continue its pharmaceutical clinical trials program in the development of cannabinoid medications for multiple medical indications.<\/span><\/p>\n<p><span style=\"font-weight: 400\">On news of AXIM\u00ae Biotechnologies obtaining its funding, the company\u2019s stock rose nearly 1000%, putting it in a competitive position among other cannabis-based pharmaceutical companies also pursuing clinical trials. <\/span><\/p>\n<p><span style=\"font-weight: 400\">AXIM\u00ae Biotechnologies\u2019 recent financing permits the company to continue in the research and development of its innovative pharmaceutical delivery systems and hemp-based pharmaceutical ingredients for the treatment of intractable conditions for which there is currently no effective remedy.<\/span><\/p>\n<h3><strong>MedChew\u00ae Rx Tested for Multiple Sclerosis<\/strong><\/h3>\n<p><span style=\"font-weight: 400\">MedChew\u00ae Rx, a cannabinoid-infused chewing gum aimed at treating the pain and spasticity in multiple sclerosis (MS), will soon undergo clinical trials in Europe.<\/span><\/p>\n<p><span style=\"font-weight: 400\">AXIM\u00ae Biotechnologies will be conducting their clinical trial on MedChew\u00ae Rx at the Free University of Amsterdam, The Netherlands. The study will be performed in collaboration with the University of Plymouth, UK, and an academic center in the U.S. The anticipated duration of the clinical trials prior to FDA\/ EMA registration is approximately twelve months.<\/span><\/p>\n<p><span style=\"font-weight: 400\">\u201cWe\u2019re extremely pleased that AXIM has received the financing it needs to continue clinical efforts with the Company\u2019s two near-term prospects. Further, the financing will allow the AXIM team of visionaries and world leaders, with proven track records, to create further cannabinoid-based innovations that may address additional indications,\u201d said Medical Marijuana, Inc. Chief Executive Officer Dr. Stuart Titus.<\/span><\/p>\n<p><span style=\"font-weight: 400\">AXIM\u00ae Biotechnologies is looking to secure MedChew\u00ae Rx as a novel, patented delivery method for cannabinoids in the treatment of chronic pain and spasticity for patients with multiple sclerosis. The potential economic impact for MedChew\u00ae Rx is estimated at $4.8 billion USD for these symptoms of MS.<\/span><\/p>\n<h3><strong>CanChew\u00ae Plus May Treat Irritable Bowel Syndrome<\/strong><\/h3>\n<p><span style=\"font-weight: 400\">The company has also begun studies involving its cannabinoid-infused CanChew\u00ae Plus Gum. The goal of these studies is to begin to determine the potential reduction of irritable bowel syndrome (IBS) symptoms in suffering patients.<\/span><\/p>\n<p><span style=\"font-weight: 400\">\u201cWe congratulate the AXIM team on reaching another major milestone in the Company\u2019s continued efforts to research new solutions using cannabinoid-based drugs,\u201d said Dr. Stuart Titus, CEO of Medical Marijuana, Inc. \u201cWe are very excited about the new formulation of CanChew Plus, which we feel will offer superior bioavailability versus our prior rendition of CanChew.\u201d<\/span><\/p>\n<p><span style=\"font-weight: 400\">Wageningen University in the Netherlands is slated to conduct the CanChew\u00ae Plus studies. The study will test 10 mg and 30 mg single dose applications for the concentration of CBD in the blood after 30 minutes. This early step will determine the administered patient dose for AXIM\u00ae Biotechnologies\u2019 Phase II trials to follow.<\/span><\/p>\n<h3><strong>Topically Applied CBG Ointment for Psoriasis and Eczema <\/strong><\/h3>\n<p><span style=\"font-weight: 400\">AXIM\u00ae Biotechnologies is also undertaking human dermatological clinical trials based on the company\u2019s proprietary, patent-pending topical ointment formulation AX-1602, which includes the \u201cstem cell cannabinoid\u201d cannabigerol (CBG) and other cannabinoids. <\/span><span style=\"font-weight: 400\">The topical application of CBG is being tested for efficacy for the skin conditions psoriasis and atopic dermatitis (eczema).<\/span><\/p>\n<p><span style=\"font-weight: 400\">AXIM\u2019s CEO, Dr. George Anastassov, states, \u201cWe are extremely pleased that our ongoing efforts in finding solutions to conditions for which there are no effective treatments&#8230; are culminating with the clinical trials of our Renecann\u2122 product. \u00a0Psoriasis and atopic dermatitis are debilitating conditions causing significant decrease in quality of life. \u00a0Utilizing our proprietary technologies and incorporating unique cannabinoids, we believe that we will be able to effectively address these concerns.\u201d<\/span><\/p>\n<p><span style=\"font-weight: 400\">The results of the AX-1602 study will determine whether the company pursues further clinical trials and a new drug application or moves to make the product available over-the-counter. <\/span><\/p>\n<h3><strong>AXIM Releases New Drug Timelines<\/strong><\/h3>\n<p><span style=\"font-weight: 400\">AXIM\u00ae Biotechnologies recently released a drug pipeline chart revealing their anticipated clinical trials. The infographic highlights the timelines established by the company for clinical trials and new drug applications. <\/span><\/p>\n<p><span style=\"font-weight: 400\">\u201cWe commend AXIM for publishing a product pipeline chart on its website as it provides potential patients and investors with critical Company information about the numerous cannabinoid-based therapeutic products that AXIM currently has undergoing clinical trials,\u201d said Medical Marijuana, Inc. Chief Executive Officer Dr. Stuart Titus. \u201cIt\u2019s exciting to see the actual timelines for these cannabinoid-based innovations currently in development, as we\u2019re confident that once on the market these novel therapeutics will provide consumers with a wide variety of new options worldwide.\u201d<\/span><\/p>\n<p><span style=\"font-weight: 400\">This clearly developed graphic shows what stage of development each AXIM\u00ae Biotechnologies product is in and gives schedules and estimated dates for completion and market introduction. As the medical marijuana industry matures, pharmaceutical applications of cannabinoids will continue to advance as well. AXIM\u00ae Biotechnologies\u2019 aggressive pursuit of clinical trials will secure their vigorous position in the cannabinoid-based pharmaceutical market.<\/span><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter wp-image-18193 size-large\" src=\"https:\/\/www.medicalmarijuanainc.com\/wp-content\/uploads\/2016\/11\/AximPipeLine-06-1024x757.png\" alt=\"aximpipeline-06\" width=\"1024\" height=\"757\" \/>    \t<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Medical Marijuana, Inc. announced this week that AXIM\u00ae Biotechnologies secured the necessary private funding needed to continue its pharmaceutical clinical trials program in the development of cannabinoid medications for multiple medical indications. On news of AXIM\u00ae Biotechnologies obtaining its funding, the company\u2019s stock rose nearly 1000%, putting it in a competitive position among other cannabis-based [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":212,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[160,3],"tags":[183],"class_list":["post-2927","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-axim-biotechnologies","category-company-news","tag-axim-biotechnologies"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v20.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Medical Marijuana, Inc. Investment Company AXIM\u00ae Biotechnologies Secures Funding for Clinical Trials - Medical Marijuana, Inc.<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/medicalmarijuanainc.com\/2016\/11\/08\/medical-marijuana-inc-investment-company-axim-biotechnologies-secures-funding-clinical-trials\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Medical Marijuana, Inc. Investment Company AXIM\u00ae Biotechnologies Secures Funding for Clinical Trials - Medical Marijuana, Inc.\" \/>\n<meta property=\"og:description\" content=\"Medical Marijuana, Inc. announced this week that AXIM\u00ae Biotechnologies secured the necessary private funding needed to continue its pharmaceutical clinical trials program in the development of cannabinoid medications for multiple medical indications. On news of AXIM\u00ae Biotechnologies obtaining its funding, the company\u2019s stock rose nearly 1000%, putting it in a competitive position among other cannabis-based [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/medicalmarijuanainc.com\/2016\/11\/08\/medical-marijuana-inc-investment-company-axim-biotechnologies-secures-funding-clinical-trials\/\" \/>\n<meta property=\"og:site_name\" content=\"Medical Marijuana, Inc.\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/MJNAInc\" \/>\n<meta property=\"article:published_time\" content=\"2016-11-08T19:15:58+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/medicalmarijuanainc.com\/wp-content\/uploads\/2016\/11\/mjna-blog-images-adding-samples-11-08-16-ver1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"500\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"adminTorusBrand\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@mjna_inc\" \/>\n<meta name=\"twitter:site\" content=\"@mjna_inc\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"adminTorusBrand\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/medicalmarijuanainc.com\/2016\/11\/08\/medical-marijuana-inc-investment-company-axim-biotechnologies-secures-funding-clinical-trials\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/medicalmarijuanainc.com\/2016\/11\/08\/medical-marijuana-inc-investment-company-axim-biotechnologies-secures-funding-clinical-trials\/\"},\"author\":{\"name\":\"adminTorusBrand\",\"@id\":\"https:\/\/medicalmarijuanainc.com\/#\/schema\/person\/bd5fa0cf1483b68c6bd5c117e3d4242c\"},\"headline\":\"Medical Marijuana, Inc. Investment Company AXIM\u00ae Biotechnologies Secures Funding for Clinical Trials\",\"datePublished\":\"2016-11-08T19:15:58+00:00\",\"dateModified\":\"2016-11-08T19:15:58+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/medicalmarijuanainc.com\/2016\/11\/08\/medical-marijuana-inc-investment-company-axim-biotechnologies-secures-funding-clinical-trials\/\"},\"wordCount\":784,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/medicalmarijuanainc.com\/#organization\"},\"keywords\":[\"AXIM Biotechnologies\"],\"articleSection\":[\"Axim Biotechnologies\",\"Company News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/medicalmarijuanainc.com\/2016\/11\/08\/medical-marijuana-inc-investment-company-axim-biotechnologies-secures-funding-clinical-trials\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/medicalmarijuanainc.com\/2016\/11\/08\/medical-marijuana-inc-investment-company-axim-biotechnologies-secures-funding-clinical-trials\/\",\"url\":\"https:\/\/medicalmarijuanainc.com\/2016\/11\/08\/medical-marijuana-inc-investment-company-axim-biotechnologies-secures-funding-clinical-trials\/\",\"name\":\"Medical Marijuana, Inc. Investment Company AXIM\u00ae Biotechnologies Secures Funding for Clinical Trials - Medical Marijuana, Inc.\",\"isPartOf\":{\"@id\":\"https:\/\/medicalmarijuanainc.com\/#website\"},\"datePublished\":\"2016-11-08T19:15:58+00:00\",\"dateModified\":\"2016-11-08T19:15:58+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/medicalmarijuanainc.com\/2016\/11\/08\/medical-marijuana-inc-investment-company-axim-biotechnologies-secures-funding-clinical-trials\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/medicalmarijuanainc.com\/2016\/11\/08\/medical-marijuana-inc-investment-company-axim-biotechnologies-secures-funding-clinical-trials\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/medicalmarijuanainc.com\/2016\/11\/08\/medical-marijuana-inc-investment-company-axim-biotechnologies-secures-funding-clinical-trials\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/medicalmarijuanainc.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Medical Marijuana, Inc. Investment Company AXIM\u00ae Biotechnologies Secures Funding for Clinical Trials\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/medicalmarijuanainc.com\/#website\",\"url\":\"https:\/\/medicalmarijuanainc.com\/\",\"name\":\"Medical Marijuana, Inc.\",\"description\":\"We are a company of firsts\u00ae\ufe0f. Medical Marijuana, Inc. (MJNA) is a cannabis company with three distinct business units in the non-psychoactive cannabinoid space. Through its subsidiaries, Medical Marijuana, Inc. manufacturers and sells some of the best cannabidiol (CBD), and other cannabinoid-based products, available!\",\"publisher\":{\"@id\":\"https:\/\/medicalmarijuanainc.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/medicalmarijuanainc.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/medicalmarijuanainc.com\/#organization\",\"name\":\"Medical Marijuana, Inc.\",\"url\":\"https:\/\/medicalmarijuanainc.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/medicalmarijuanainc.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/medicalmarijuanainc.com\/wp-content\/uploads\/2023\/02\/cropped-logo-medical-marijuana-inc.png\",\"contentUrl\":\"https:\/\/medicalmarijuanainc.com\/wp-content\/uploads\/2023\/02\/cropped-logo-medical-marijuana-inc.png\",\"width\":512,\"height\":512,\"caption\":\"Medical Marijuana, Inc.\"},\"image\":{\"@id\":\"https:\/\/medicalmarijuanainc.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/MJNAInc\",\"https:\/\/twitter.com\/mjna_inc\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/medicalmarijuanainc.com\/#\/schema\/person\/bd5fa0cf1483b68c6bd5c117e3d4242c\",\"name\":\"adminTorusBrand\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/medicalmarijuanainc.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/a912c97701c52370233e20a0d17ab853?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/a912c97701c52370233e20a0d17ab853?s=96&d=mm&r=g\",\"caption\":\"adminTorusBrand\"},\"sameAs\":[\"https:\/\/medicalmarijuanainc.com\"],\"url\":\"https:\/\/medicalmarijuanainc.com\/author\/admintorusbrand\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Medical Marijuana, Inc. Investment Company AXIM\u00ae Biotechnologies Secures Funding for Clinical Trials - Medical Marijuana, Inc.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/medicalmarijuanainc.com\/2016\/11\/08\/medical-marijuana-inc-investment-company-axim-biotechnologies-secures-funding-clinical-trials\/","og_locale":"en_US","og_type":"article","og_title":"Medical Marijuana, Inc. Investment Company AXIM\u00ae Biotechnologies Secures Funding for Clinical Trials - Medical Marijuana, Inc.","og_description":"Medical Marijuana, Inc. announced this week that AXIM\u00ae Biotechnologies secured the necessary private funding needed to continue its pharmaceutical clinical trials program in the development of cannabinoid medications for multiple medical indications. On news of AXIM\u00ae Biotechnologies obtaining its funding, the company\u2019s stock rose nearly 1000%, putting it in a competitive position among other cannabis-based [&hellip;]","og_url":"https:\/\/medicalmarijuanainc.com\/2016\/11\/08\/medical-marijuana-inc-investment-company-axim-biotechnologies-secures-funding-clinical-trials\/","og_site_name":"Medical Marijuana, Inc.","article_publisher":"https:\/\/www.facebook.com\/MJNAInc","article_published_time":"2016-11-08T19:15:58+00:00","og_image":[{"width":1200,"height":500,"url":"https:\/\/medicalmarijuanainc.com\/wp-content\/uploads\/2016\/11\/mjna-blog-images-adding-samples-11-08-16-ver1.png","type":"image\/png"}],"author":"adminTorusBrand","twitter_card":"summary_large_image","twitter_creator":"@mjna_inc","twitter_site":"@mjna_inc","twitter_misc":{"Written by":"adminTorusBrand","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/medicalmarijuanainc.com\/2016\/11\/08\/medical-marijuana-inc-investment-company-axim-biotechnologies-secures-funding-clinical-trials\/#article","isPartOf":{"@id":"https:\/\/medicalmarijuanainc.com\/2016\/11\/08\/medical-marijuana-inc-investment-company-axim-biotechnologies-secures-funding-clinical-trials\/"},"author":{"name":"adminTorusBrand","@id":"https:\/\/medicalmarijuanainc.com\/#\/schema\/person\/bd5fa0cf1483b68c6bd5c117e3d4242c"},"headline":"Medical Marijuana, Inc. Investment Company AXIM\u00ae Biotechnologies Secures Funding for Clinical Trials","datePublished":"2016-11-08T19:15:58+00:00","dateModified":"2016-11-08T19:15:58+00:00","mainEntityOfPage":{"@id":"https:\/\/medicalmarijuanainc.com\/2016\/11\/08\/medical-marijuana-inc-investment-company-axim-biotechnologies-secures-funding-clinical-trials\/"},"wordCount":784,"commentCount":0,"publisher":{"@id":"https:\/\/medicalmarijuanainc.com\/#organization"},"keywords":["AXIM Biotechnologies"],"articleSection":["Axim Biotechnologies","Company News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/medicalmarijuanainc.com\/2016\/11\/08\/medical-marijuana-inc-investment-company-axim-biotechnologies-secures-funding-clinical-trials\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/medicalmarijuanainc.com\/2016\/11\/08\/medical-marijuana-inc-investment-company-axim-biotechnologies-secures-funding-clinical-trials\/","url":"https:\/\/medicalmarijuanainc.com\/2016\/11\/08\/medical-marijuana-inc-investment-company-axim-biotechnologies-secures-funding-clinical-trials\/","name":"Medical Marijuana, Inc. Investment Company AXIM\u00ae Biotechnologies Secures Funding for Clinical Trials - Medical Marijuana, Inc.","isPartOf":{"@id":"https:\/\/medicalmarijuanainc.com\/#website"},"datePublished":"2016-11-08T19:15:58+00:00","dateModified":"2016-11-08T19:15:58+00:00","breadcrumb":{"@id":"https:\/\/medicalmarijuanainc.com\/2016\/11\/08\/medical-marijuana-inc-investment-company-axim-biotechnologies-secures-funding-clinical-trials\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/medicalmarijuanainc.com\/2016\/11\/08\/medical-marijuana-inc-investment-company-axim-biotechnologies-secures-funding-clinical-trials\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/medicalmarijuanainc.com\/2016\/11\/08\/medical-marijuana-inc-investment-company-axim-biotechnologies-secures-funding-clinical-trials\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/medicalmarijuanainc.com\/"},{"@type":"ListItem","position":2,"name":"Medical Marijuana, Inc. Investment Company AXIM\u00ae Biotechnologies Secures Funding for Clinical Trials"}]},{"@type":"WebSite","@id":"https:\/\/medicalmarijuanainc.com\/#website","url":"https:\/\/medicalmarijuanainc.com\/","name":"Medical Marijuana, Inc.","description":"We are a company of firsts\u00ae\ufe0f. Medical Marijuana, Inc. (MJNA) is a cannabis company with three distinct business units in the non-psychoactive cannabinoid space. Through its subsidiaries, Medical Marijuana, Inc. manufacturers and sells some of the best cannabidiol (CBD), and other cannabinoid-based products, available!","publisher":{"@id":"https:\/\/medicalmarijuanainc.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/medicalmarijuanainc.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/medicalmarijuanainc.com\/#organization","name":"Medical Marijuana, Inc.","url":"https:\/\/medicalmarijuanainc.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/medicalmarijuanainc.com\/#\/schema\/logo\/image\/","url":"https:\/\/medicalmarijuanainc.com\/wp-content\/uploads\/2023\/02\/cropped-logo-medical-marijuana-inc.png","contentUrl":"https:\/\/medicalmarijuanainc.com\/wp-content\/uploads\/2023\/02\/cropped-logo-medical-marijuana-inc.png","width":512,"height":512,"caption":"Medical Marijuana, Inc."},"image":{"@id":"https:\/\/medicalmarijuanainc.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/MJNAInc","https:\/\/twitter.com\/mjna_inc"]},{"@type":"Person","@id":"https:\/\/medicalmarijuanainc.com\/#\/schema\/person\/bd5fa0cf1483b68c6bd5c117e3d4242c","name":"adminTorusBrand","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/medicalmarijuanainc.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/a912c97701c52370233e20a0d17ab853?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a912c97701c52370233e20a0d17ab853?s=96&d=mm&r=g","caption":"adminTorusBrand"},"sameAs":["https:\/\/medicalmarijuanainc.com"],"url":"https:\/\/medicalmarijuanainc.com\/author\/admintorusbrand\/"}]}},"_links":{"self":[{"href":"https:\/\/medicalmarijuanainc.com\/wp-json\/wp\/v2\/posts\/2927","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicalmarijuanainc.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicalmarijuanainc.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicalmarijuanainc.com\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/medicalmarijuanainc.com\/wp-json\/wp\/v2\/comments?post=2927"}],"version-history":[{"count":0,"href":"https:\/\/medicalmarijuanainc.com\/wp-json\/wp\/v2\/posts\/2927\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medicalmarijuanainc.com\/wp-json\/wp\/v2\/media\/212"}],"wp:attachment":[{"href":"https:\/\/medicalmarijuanainc.com\/wp-json\/wp\/v2\/media?parent=2927"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicalmarijuanainc.com\/wp-json\/wp\/v2\/categories?post=2927"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicalmarijuanainc.com\/wp-json\/wp\/v2\/tags?post=2927"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}